What Toxicology Testing Reveals During Recovery

Register for our Next Live Webinar Presentation

What Toxicology Testing Reveals During Recovery

Date: October 28, 2026 | Time: 9am or 1pm (CT)

Please join us for an educational webinar on Wednesday, October 28, 2026, hosted by Katie Liveoak, Pharm.D., BCPP, Clinical Pharmacist, Aegis Sciences Corporation. Dr. Liveoak will discuss Aegis longitudinal toxicology monitoring results what was revealed during the first year of recovery.

Webinar Objectives:

• Describe changes in fentanyl and polydrug detection during the first year of OUD treatment
• Evaluate patient-level toxicology analyses and their impact on clinical interpretation
• Recognize patterns of improvement, persistence, and recurrence during longitudinal monitoring
• Discuss how longitudinal toxicology data can complement clinical assessment of recovery trajectories
• Apply longitudinal testing concepts to identify patients who may benefit from additional intervention or treatment modification

This session is ideal for clinicians, public health professionals, toxicologists, substance use treatment providers, and others involved in prevention, monitoring, and response efforts. Don’t miss this opportunity to enhance your understanding of longitudinal toxicology monitoring, and how it provides clinicians with a more complete understanding of recovery trajectories than cross-sectional testing alone.